Publicado el

Nevada Donor Network closer to opening statewide transplant institute

Loading

Since 2019, the Nevada Donor Network Foundation has been on a mission to bring a new transplant institute to Nevada. 

And due to a recent investment of American Rescue Plan Act funds, the nonprofit has gotten closer to bringing the institute to life. 

But why a new transplant institute? Especially since there is already a center for transplantation at University Medical Center. To answer that is Joe Ferreira, the CEO and president of the Nevada Donor Network. Check out the full story from Nevada Public Radio.

Loading
Publicado el

CareDx Demonstrates Power of AlloSure and Digital Health Transplant Solutions at American Society of Nephrology Kidney Week

Loading

NOVEMBER, 02, 2022

CareDx Showcases Latest Innovations in Pre- and Post-Transplant Patient Care

BRISBANE, Calif.–(BUSINESS WIRE)– CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that it will be sharing the latest data on AlloSure® Kidney and its patient-centered digital health solutions at the American Society of Nephrology (ASN) Kidney Week 2022 meeting being held November 3 – 6 in Orlando, Florida.
Read the complete press release on CareDx.com.

Loading
Publicado el

Hearts from COVID-19-positive donors appear safe for transplant

Loading

Donor hearts from people with COVID-19 may be just as safe as those from people without, finds a short-term analysis of the first such transplants done in the United States.

“These findings suggest that we may be able to be more aggressive about accepting donors that are positive for COVID-19 when patients are in dire need of an organ for heart transplantation,” study researcher Samuel T. Kim said in a news release. Kim is a third-year medical student at the David Geffen School of Medicine at the University of California, Los Angeles. Read more from American Heart Association News.

Loading
Publicado el

Independent Longitudinal Study Finds CareDx’s AlloSure Detects Early Signs of Rejection in Pediatric Kidney Transplant Patients

Loading

NOVEMBER, 01, 2022

First Pediatric Study to Evaluate Use of AlloSure dd-cfDNA as Biomarker for Allograft BK Infection

Findings Add to Growing Body of Evidence Showing Clinical Value of AlloSure for Surveillance in Pediatric Kidney Transplant Patients

BRISBANE, Calif.–(BUSINESS WIRE)– CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced the results of a new study published in the Clinical Journal of the American Society of Nephrology (CJASN)1 showing that CareDx’s AlloSure® Kidney donor-derived cell-free DNA (dd-cfDNA) solution identifies early signs of allograft rejection and BK virus infection in pediatric kidney transplant patients.
Read the complete press release on CareDx.com.

Loading
Publicado el

Kidney Transplant Recipients Have Insufficient Immunity During COVID-19 Illness

Loading

Investigators have found evidence of reduced T cell immunity during COVID-19 illness followed by T cell recovery in kidney transplant recipients. Insufficient immunity appears to occur despite initial reduction of antirejection medications in these patients.

Most centers have empirically reduced anti-rejection immunosuppression in kidney transplant recipients with COVID-19 due to concerns that immunosuppressant use would hinder anti-COVID-19 immunity, Madhav C. Menon, MBBS, of Yale University in New Haven, Connecticut, and colleagues explained in the Journal of the American Society of Nephrology. Read more in Renal & Urology News.

Loading
Publicado el

Innovative Clinical Trial Targets Recurrent BK Infection in Kidney Transplant Recipients

Loading

Kidney transplant patients like Tessa Adolph, from Rockford, Illinois, face an age-old problem to protect their new kidney and bodies after transplant surgery: how to prevent infections while also safeguarding their new kidney from damage or rejection.

In Adolph’s case, the risk came from the BK virus.

At 19, she was diagnosed with Henoch-Schönlein purpura, a rare condition that causes small blood vessels in the body organs, including kidneys, to become inflamed and bleed. This transitioned into a condition called IgA nephropathy, or Berger’s disease, that over time can cause kidney scarring and eventual kidney failure, she said. Read the full article from UW School of Medicine and Public Health.


Loading
Publicado el

Managing and Preventing Diabetes After an Organ Transplant

Loading

Complications of posttransplant diabetes mellitus can develop quickly, but appropriate management may prevent them.

People with end-stage kidney disease achieve better quality of life and survival rates with a kidney transplant than with dialysis, but if they develop posttransplant diabetes mellitus (PTDM), they are at high risk for rapidly developing cardiovascular disease or other complications. Maria Paula Martinez-Cantarin, MD, a nephrologist and researcher at Thomas Jefferson University, describes how physicians can manage PTDM and prevent complications. Read the full article from National Institute of Diabetes and Digestive and Kidney Diseases.

Loading